APA (7th ed.) Citation

L, R., AT, B., A, L. G., D, H., JG, C., W, S., . . . M, N. (2026). Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement. Rheumatology (Oxford, England), 65(3), . https://doi.org/10.1093/rheumatology/keag109

Chicago Style (17th ed.) Citation

L, Ross, et al. "Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart Involvement." Rheumatology (Oxford, England) 65, no. 3 (2026). https://doi.org/10.1093/rheumatology/keag109.

MLA (9th ed.) Citation

L, Ross, et al. "Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart Involvement." Rheumatology (Oxford, England), vol. 65, no. 3, 2026, https://doi.org/10.1093/rheumatology/keag109.